Record NNP B-NP O
date NN I-NP O
: : O O
2103-09-02 CD O B-DATE
September NNP B-NP B-DATE
02 CD I-NP I-DATE
, , I-NP I-DATE
2103 CD O I-DATE
Odessia NNP B-NP B-DOCTOR
Kay NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
Willow NNP B-NP B-HOSPITAL
Pointe NNP I-NP I-HOSPITAL
Assisted NNP I-NP I-HOSPITAL
Living NNP I-NP I-HOSPITAL
Center NNP I-NP I-HOSPITAL
600 CD B-NP B-STREET
Cherry NNP I-NP I-STREET
Street NNP I-NP I-STREET
Aumsville NNP B-NP B-CITY
, , O O
IA NNP B-NP B-STATE
63482 CD I-NP B-ZIP
Re NNP B-NP O
: : O O
Dalila NNP B-NP B-PATIENT
Haynes NNP I-NP I-PATIENT
783-61-34-3 . O B-MEDICALRECORD
Dear NNP B-NP O
Dr. NNP I-NP O
Kay NNP I-NP B-DOCTOR
: : O O
I PRP B-NP O
saw VBD B-VP O
Dalila NNP B-NP B-PATIENT
Haynes NNP I-NP I-PATIENT
today NN I-NP O
in IN B-PP O
consultation NN B-NP O
concerning VBG B-VP O
the DT B-NP O
possibility NN I-NP O
of IN B-PP O
neurosarcoidosis NN B-NP O
. . O O
She PRP B-NP O
comes VBZ B-VP O
with IN B-PP O
her PRP$ B-NP O
daughter NN I-NP O
who WP B-NP O
assists VBZ B-VP O
with IN B-PP O
the DT B-NP O
history NN I-NP O
. . O O
I PRP B-NP O
will MD B-VP O
review VB I-VP O
her PRP$ B-NP O
history NN I-NP O
for IN B-PP O
the DT B-NP O
record NN I-NP O
. . O O
She PRP B-NP O
is VBZ B-VP O
a DT B-NP O
69 CD I-NP B-AGE
-year-old JJ I-NP O
right-handed JJ I-NP O
woman NN I-NP O
who WP B-NP O
was VBD B-VP O
hospitalized VBN I-VP O
at IN B-PP O
the DT B-NP O
Promptcare NNP I-NP B-HOSPITAL
in IN B-PP O
July NNP B-NP B-DATE
2103 CD I-NP I-DATE
for IN B-PP O
evaluation NN B-NP O
of IN B-PP O
mental JJ B-NP O
and CC I-NP O
motor NN I-NP O
slowing NN I-NP O
, , O O
memory NN B-NP O
loss NN I-NP O
, , O O
and CC O O
weight NN B-NP O
loss NN I-NP O
. . O O
Her PRP$ B-NP O
daughter NN I-NP O
notes VBZ B-VP O
that IN B-SBAR O
she PRP B-NP O
had VBD B-VP O
deteriorated VBN I-VP O
over IN B-PP O
the DT B-NP O
course NN I-NP O
of IN B-PP O
a DT B-NP O
month NN I-NP O
or CC I-NP O
two CD I-NP O
. . O O
Her PRP$ B-NP O
movements NNS I-NP O
slowed VBD B-VP O
down RP B-ADJP O
, , O O
and CC O O
she PRP B-NP O
became VBD B-VP O
unsteady JJ B-ADJP O
on IN B-PP O
her PRP$ B-NP O
feet NNS I-NP O
, , O O
and CC O O
her PRP$ B-NP O
memory NN I-NP O
deteriorated VBN B-VP O
. . O O
This DT B-NP O
culminated VBN B-VP O
in IN B-PP O
a DT B-NP O
fall NN I-NP O
in IN B-PP O
July NNP B-NP B-DATE
prompting VBG B-VP O
her PRP$ B-NP O
hospitalization NN I-NP O
. . O O
During IN B-PP O
that DT B-NP O
hospitalization NN I-NP O
a DT B-NP O
head NN I-NP O
CT NN I-NP O
on IN B-PP O
7/25/03 CD B-NP B-DATE
was VBD B-VP O
reported VBN I-VP O
unremarkable JJ B-ADJP O
. . O O
( -LRB- O O
There EX B-NP O
is VBZ B-VP O
mild JJ I-VP O
ventriculomegaly RB B-ADVP O
on IN B-PP O
it PRP B-NP O
. . O O
) -RRB- O O
An DT O O
MRI NNP O O
of IN B-PP O
the DT B-NP O
brain NN I-NP O
on IN B-PP O
7/28 CD B-NP B-DATE
showed VBD B-VP O
a DT B-NP O
few JJ I-NP O
dots NNS I-NP O
of IN B-PP O
restricted JJ B-NP O
diffusion NN I-NP O
in IN B-PP O
the DT B-NP O
left JJ I-NP O
thalamus NN I-NP O
. . O O
There EX B-NP O
was VBD B-VP O
no DT B-NP O
abnormal JJ I-NP O
enhancement NN I-NP O
. . O O
This DT O O
was VBD B-VP O
consistent JJ B-ADJP O
with IN B-PP O
small JJ B-NP O
vessel NN I-NP O
stroke NN I-NP O
. . O O
EEG PRP B-NP O
showed VBD B-VP O
generalized JJ B-NP O
slowing NN I-NP O
of IN B-PP O
the DT B-NP O
background NN I-NP O
in IN B-PP O
the DT B-NP O
theta NN I-NP O
and CC I-NP O
delta JJ I-NP O
range NN I-NP O
with IN B-PP O
no DT B-NP O
epileptiform NN I-NP O
features NNS B-VP O
. . O O
An DT B-NP O
LP NNP I-NP O
showed VBD B-VP O
normal JJ B-NP O
glucose NN I-NP O
( -LRB- I-NP O
74) JJ I-NP O
, , I-NP O
elevated JJ I-NP O
protein NN I-NP O
( -LRB- I-NP O
102 CD I-NP O
) -RRB- I-NP O
, , I-NP O
lymphocytic JJ I-NP O
pleocytosis NN I-NP O
( -LRB- I-NP O
18-20 CD I-NP O
WBC NNP I-NP O
, , O O
56-69 CD B-NP O
% NN I-NP O
lymphocytes NNS I-NP O
, , O O
29-40 CD B-NP O
% NN I-NP O
monocytes NNS I-NP O
, , O O
and CC O O
2-4 CD B-NP O
% NN I-NP O
neutrophils NNS I-NP O
) -RRB- O O
and CC O O
0-1 JJ B-NP O
RBC NNP I-NP O
. . I-NP O
CSF NNP I-NP O
ACE NNP I-NP O
was VBD B-VP O
normal JJ B-NP O
. . B-NP O
Cultures NNPS I-NP O
were VBD B-VP O
negative JJ B-ADJP O
. . O O
CSF NNP B-NP O
VDRL NNP I-NP O
was VBD B-VP O
negative JJ B-ADJP O
. . O O
Because IN B-SBAR O
she PRP B-NP O
has VBZ B-VP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
sarcoidosis NN B-NP O
, , O O
it PRP B-NP O
was VBD B-VP O
thought VBN I-VP O
that IN B-PP O
this DT B-NP O
likely JJ I-NP O
represented VBD I-NP O
neurosarcoidosis NN I-NP O
. . O O
She PRP B-NP O
was VBD B-VP O
started VBN I-VP O
on IN B-PP O
prednisone NN B-NP O
40 CD I-NP O
mg NN I-NP O
daily RB B-ADVP O
. . O O
Her PRP$ B-NP O
daughter NN I-NP O
has VBZ B-VP O
noted VBN I-VP O
some DT B-NP O
improvement NN I-NP O
in IN B-PP O
her PRP$ B-NP O
movements NNS I-NP O
and CC I-NP O
cognition NN I-NP O
since IN B-PP O
starting VBG B-VP O
the DT B-NP O
prednisone NN I-NP O
, , O O
but CC O O
she PRP B-NP O
remains VBZ B-VP O
abnormal JJ B-ADJP O
. . O O
She PRP B-NP O
has VBZ B-VP O
lowered VBN I-VP O
the DT B-NP O
prednisone NN I-NP O
to TO I-NP O
10 CD I-NP O
mg NN I-NP O
daily RB B-ADVP O
now RB I-ADVP O
. . O O
Reviewing VBG B-VP O
the DT B-NP O
laboratory NN I-NP O
studies NNS I-NP O
today NN I-NP O
, , O O
I PRP B-NP O
see VBP B-VP O
that IN B-SBAR O
although IN B-PP O
an DT B-NP O
RPR NN I-NP O
was VBD B-VP O
non-reactive JJ B-ADJP O
, , O O
a DT B-NP O
TA-IgG NNP I-NP O
was VBD B-VP O
positive JJ B-ADJP O
, , O O
and CC O O
the DT B-NP O
confirming VBG I-NP O
treponemal NN I-NP O
tests NNS I-NP O
(FTA IN B-PP O
) -RRB- B-NP O
was VBD B-VP O
also RB B-ADVP O
positive JJ B-ADJP O
at IN B-PP O
the DT B-NP O
state NN I-NP O
lab NN I-NP O
. . O O
She PRP B-NP O
and CC O O
her PRP$ B-NP O
daughter NN I-NP O
are VBP B-VP O
aware JJ B-ADJP O
of IN B-PP O
no DT B-NP O
prior JJ I-NP O
history NN I-NP O
of IN B-PP O
syphilis NN B-NP O
. . O O
Other JJ B-NP O
studies NNS I-NP O
during IN B-PP O
her PRP$ B-NP O
hospitalization NN I-NP O
included VBD B-VP O
low JJ B-NP O
serum NN I-NP O
Na NNP I-NP O
( -LRB- I-NP O
133 CD I-NP O
) -RRB- I-NP O
and CC I-NP O
Mg NNP I-NP O
( -LRB- I-NP O
1.3 CD I-NP O
) -RRB- B-NP O
, , O O
normal JJ B-NP O
vitamin NN I-NP O
B12 NN I-NP O
, , O O
folate JJ B-NP O
, , O O
TSH NNP B-NP O
, , O O
and CC O O
ESR NNP B-NP O
( -LRB- I-NP O
20 CD I-NP O
) -RRB- I-NP O
. . O O
CSF NNP B-NP O
HSV NNP I-NP O
PCR NNP I-NP O
was VBD B-VP O
negative JJ B-ADJP O
. . O O
HbA1C NNP B-NP O
was VBD B-VP O
elevated VBN I-VP O
at IN B-PP O
8.6. CD B-NP O
She PRP B-NP O
has VBZ B-VP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
asthma NN B-NP O
going VBG B-VP O
back RB B-ADVP O
many JJ B-NP O
years NNS I-NP O
. . O O
According VBG B-VP O
to TO B-PP O
her PRP$ B-NP O
daughter NN I-NP O
, , O O
she PRP B-NP O
had VBD B-VP O
a DT B-NP O
skin NN I-NP O
lesion NN I-NP O
excised VBN B-VP O
from IN B-ADVP O
near IN B-PP O
her PRP$ B-NP O
left JJ I-NP O
eye NN I-NP O
about IN B-PP O
two CD B-NP O
years NNS I-NP O
ago RB B-ADVP O
. . O O
Apparently RB B-ADVP O
, , O O
this DT B-NP O
showed VBD B-VP O
noncaseated JJ B-NP O
granuloma NN I-NP O
, , O O
and CC O O
that DT B-NP O
is VBZ B-VP O
when WRB B-ADVP O
the DT B-NP O
diagnosis NN I-NP O
of IN B-PP O
sarcoidosis NN B-NP O
was VBD B-VP O
first RB I-VP O
made VBN I-VP O
. . O O
She PRP B-NP O
then RB B-ADVP O
had VBD B-VP O
a DT B-NP O
mediatinoscopy NN I-NP O
on IN B-PP O
4/10/02 CD B-NP B-DATE
. . O O
Biopsy NNP O O
of IN B-PP O
mediastinal JJ B-NP O
nodes NNS I-NP O
showed VBD B-VP O
granulomatous JJ B-NP O
inflammation NN I-NP O
without IN B-PP O
caseating VBG B-VP O
necrosis NN B-NP O
, , O O
supporting VBG B-VP O
the DT B-NP O
diagnosis NN I-NP O
of IN B-PP O
sarcoidosis NN B-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
type NN B-NP O
II NNP I-NP O
DM NNP I-NP O
, , O O
HTN NNP B-NP O
, , O O
hypercholesterolemia NN B-NP O
, , O O
GERD NNP B-NP O
, , O O
and CC O O
she PRP B-NP O
has VBZ B-VP O
had VBN I-VP O
a DT B-NP O
thyroid JJ I-NP O
adenoma NN I-NP O
. . O O
Her PRP$ B-NP O
current JJ I-NP O
medications NNS I-NP O
are VBP B-VP O
prednisone RB B-NP O
10 CD I-NP O
mg JJ I-NP O
daily JJ I-NP O
, , I-NP O
aspirin JJ I-NP O
81 CD I-NP O
mg JJ I-NP O
daily JJ I-NP O
, , I-NP O
troglitazone NN I-NP O
, , I-NP O
metformin NN I-NP O
, , I-NP O
glyburide NN I-NP O
, , I-NP O
sisinoril NN I-NP O
, , I-NP O
pravastatin NN I-NP O
, , I-NP O
vitamin NN I-NP O
D NNP I-NP O
, , O O
calcium NN B-NP O
CO3 NN I-NP O
, , O O
Colace NNP B-NP O
, , O O
and CC O O
an DT B-NP O
inhaler NN I-NP O
for IN B-PP O
her PRP$ B-NP O
asthma NN I-NP O
as IN B-PP O
needed VBN B-NP O
. . O O
She PRP B-NP O
is VBZ B-VP O
allergic JJ B-ADJP O
to TO B-PP O
sulfa NN B-NP O
agents NNS I-NP O
and CC O O
to TO B-VP O
fluticasone VB I-VP O
nasal JJ B-NP O
spray NN I-NP O
. . O O
There EX B-NP O
is VBZ B-VP O
no DT B-NP O
history NN I-NP O
of IN B-PP O
allergy NN B-NP O
to TO B-PP O
PCN. NNP B-NP O
Her PRP$ B-NP O
parents NNS I-NP O
both DT B-NP O
died VBD B-VP O
of IN B-PP O
some DT B-NP O
type NN I-NP O
of IN B-PP O
cancer NN B-NP O
. . O O
There EX B-NP O
is VBZ B-VP O
no DT B-NP O
family NN I-NP O
history NN I-NP O
of IN B-PP O
sarcoidosis NN B-NP O
or CC B-PP O
of IN B-PP O
neurologic JJ B-NP O
disease NN I-NP O
. . O O
She PRP B-NP O
is VBZ B-VP O
a DT B-NP O
widow NN I-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
four CD B-NP O
children NNS I-NP O
. . O O
She PRP B-NP O
used VBD B-VP O
to TO I-VP O
work VB I-VP O
for IN B-PP O
Lowe NNP B-NP I-ORGANIZATION
's POS B-NP I-ORGANIZATION
. . O O
She PRP B-NP O
now RB B-ADVP O
lives VBZ B-VP O
with IN B-PP O
a DT B-NP O
daughter NN I-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
had VBN I-VP O
no DT B-NP O
recent JJ I-NP O
fever NN I-NP O
or CC I-NP O
chills NNS I-NP O
. . O O
Her PRP$ B-NP O
weight NN I-NP O
has VBZ B-VP O
been VBN I-VP O
stable JJ B-ADJP O
and CC O O
her PRP$ B-NP O
appetite NN I-NP O
good JJ I-NP O
. . O O
There EX B-NP O
is VBZ B-VP O
no DT B-NP O
history NN I-NP O
of IN B-PP O
exertional JJ B-NP O
chest NN I-NP O
pain NN I-NP O
or CC I-NP O
palpitations NNS I-NP O
. . O O
There EX B-NP O
is VBZ B-VP O
no DT B-NP O
history NN I-NP O
of IN B-PP O
cough NN B-NP O
, , I-NP O
dyspnea NN I-NP O
, , I-NP O
nausea NN I-NP O
, , O O
vomiting VBG B-VP O
, , O O
or CC O O
diarrhea NN B-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
had VBN I-VP O
no DT B-NP O
rash NN I-NP O
or CC I-NP O
joint JJ I-NP O
symptoms NNS I-NP O
. . O O
Pulse NNP B-NP O
126 CD I-NP O
, , O O
regular JJ B-ADJP O
. . O O
BP NNP B-NP O
126/66 CD I-NP O
. . O O
She PRP B-NP O
is VBZ B-VP O
obese JJ B-ADJP O
. . O O
Ears NNS B-NP O
, , O O
nose NN B-NP O
, , O O
and CC O O
throat NN B-NP O
are VBP B-VP O
clear JJ B-ADJP O
. . O O
There EX B-NP O
are VBP B-VP O
no DT B-NP O
cranial JJ I-NP O
bruits NNS I-NP O
. . O O
The DT B-NP O
neck NN I-NP O
is VBZ B-VP O
supple NN B-NP O
with IN B-PP O
full JJ B-NP O
carotid NN I-NP O
pulses NNS I-NP O
and CC O O
no DT B-NP O
bruits NNS I-NP O
. . O O
There EX B-NP O
are VBP B-VP O
wheezes NNS B-NP O
bilaterally RB B-ADVP O
. . O O
The DT B-NP O
heart NN I-NP O
is VBZ B-VP O
regular JJ B-ADJP O
with IN B-PP O
no DT B-NP O
murmur NN I-NP O
. . O O
The DT B-NP O
abdomen NN I-NP O
is VBZ B-VP O
benign JJ B-ADJP O
. . O O
The DT B-NP O
extremities NNS I-NP O
are VBP B-VP O
normal JJ B-ADJP O
. . O O
There EX B-NP O
is VBZ B-VP O
general JJ B-NP O
psychomotor NN I-NP O
slowing VBG I-NP O
. . O O
She PRP B-NP O
is VBZ B-VP O
oriented VBN I-VP O
to TO B-PP O
time NN B-NP O
, , O O
expect VBP B-VP O
that IN B-SBAR O
she PRP B-NP O
gets VBZ B-VP O
the DT B-NP O
date NN I-NP O
off RP B-NP O
by IN B-PP O
two CD B-NP O
days NNS I-NP O
as IN B-PP O
Aug NNP B-NP B-DATE
31 CD I-NP I-DATE
. . O O
She PRP B-NP O
is VBZ B-VP O
oriented VBN I-VP O
to TO B-VP O
place VB I-VP O
. . O O
She PRP B-NP O
is VBZ B-VP O
inattentive JJ B-ADJP O
. . O O
She PRP B-NP O
is VBZ B-VP O
able JJ B-ADJP O
to TO B-VP O
recite VB I-VP O
the DT B-NP O
months NNS I-NP O
in IN B-PP O
order NN B-NP O
, , O O
but CC O O
she PRP B-NP O
gets VBZ B-VP O
lost VBN I-VP O
trying VBG I-VP O
to TO I-VP O
recite VB I-VP O
them PRP B-NP O
in IN B-PP O
reverse NN B-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
trouble NN B-NP O
registering VBG B-VP O
4 CD B-NP O
words NNS I-NP O
, , O O
and CC O O
she PRP B-NP O
recalls VBZ B-VP O
only RB B-NP O
2 CD I-NP O
of IN I-NP O
4 CD I-NP O
after IN B-PP O
three CD B-NP O
minutes NNS I-NP O
. . O O
There EX B-NP O
is VBZ B-VP O
no DT B-NP O
aphasia NN I-NP O
. . O O
She PRP B-NP O
cannot MD B-VP O
copy VB I-VP O
interlocking VBG I-VP O
pentagons NNS B-NP O
and CC O O
her PRP$ B-NP O
copy NN I-NP O
of IN B-PP O
a DT B-NP O
3D JJ I-NP O
cube NN I-NP O
shows VBZ B-VP O
poor JJ B-NP O
spacial JJ I-NP O
representation NN I-NP O
. . O O
The DT B-NP O
visual JJ I-NP O
fields NNS I-NP O
are VBP B-VP O
full JJ B-ADJP O
. . O O
The DT B-NP O
pupils NNS I-NP O
are VBP B-VP O
3 CD B-NP O
mm CD I-NP O
and CC O O
normally RB B-VP O
reactive VB I-VP O
. . O O
The DT B-NP O
fundi NN I-NP O
are VBP B-VP O
poorly RB I-VP O
visualized VBN I-VP O
. . O O
. . O O
The DT B-NP O
eye NN I-NP O
movements NNS I-NP O
are VBP B-VP O
full JJ B-ADJP O
and CC I-ADJP O
conjugate JJ I-ADJP O
with IN B-PP O
no DT B-NP O
nystagmus NN I-NP O
; : O O
pursuit NN B-NP O
movement NN I-NP O
are VBP B-VP O
saccadic JJ B-ADJP O
. . O O
Facial NNP B-NP O
sensation NN I-NP O
is VBZ B-VP O
intact JJ B-ADJP O
. . O O
Facial JJ B-NP O
power NN I-NP O
is VBZ B-VP O
normal JJ B-ADJP O
and CC I-ADJP O
symmetric JJ I-ADJP O
. . B-NP O
Hearing VBG I-NP O
is VBZ B-VP O
grossly RB B-ADJP O
intact JJ I-ADJP O
. . O O
Weber NNP B-NP O
and CC O O
Rinne NNP B-NP O
tests NNS I-NP O
are VBP B-VP O
normal JJ B-ADJP O
. . O O
The DT B-NP O
palate NN I-NP O
elevates VBZ B-VP O
normal JJ B-ADJP O
. . O O
Gag NNP B-NP O
is VBZ B-VP O
present JJ B-ADJP O
. . O O
The DT B-NP O
sternocleidomastoid NN I-NP O
and CC I-NP O
trapezius NN I-NP O
power NN I-NP O
are VBP B-VP O
normal JJ B-ADJP O
. . O O
The DT B-NP O
tongue NN I-NP O
protrudes NNS I-NP O
in IN B-PP O
the DT B-NP O
midline NN I-NP O
. . O O
Muscle NNP B-NP O
bulk NN I-NP O
, , O O
tone NN B-NP O
, , O O
and CC O O
power NN B-NP O
are VBP B-VP O
normal JJ B-ADJP O
. . O O
There EX B-NP O
is VBZ B-VP O
a DT B-NP O
low-amplitude NN I-NP O
, , O O
high-frequency NN B-NP O
tremor NN I-NP O
in IN B-PP O
action NN B-NP O
and CC I-NP O
rest NN I-NP O
. . O O
Temperature NN B-NP O
and CC O O
pinprick JJ B-NP O
sensation NN I-NP O
are VBP B-VP O
diminished VBN I-VP O
in IN B-PP O
the DT B-NP O
lower JJR I-NP O
extremities NNS I-NP O
with IN B-PP O
a DT B-NP O
distally-predominant JJ I-NP O
gradient NN I-NP O
. . O O
Reflexes NNS B-NP O
are VBP B-VP O
normal JJ B-ADJP O
( -LRB- B-NP O
2/4 CD I-NP O
) -RRB- I-NP O
and CC I-NP O
symmetric JJ I-NP O
in IN B-PP O
the DT B-NP O
upper JJ I-NP O
extremities NNS I-NP O
and CC B-PP O
at IN B-PP O
the DT B-NP O
knees NNS I-NP O
and CC I-NP O
absent JJ I-NP O
at IN B-PP O
the DT B-NP O
ankles NNS I-NP O
. . O O
Plantar NN B-NP O
responses NNS I-NP O
are VBP B-VP O
flexor JJ B-ADJP O
. . O O
Coordination NNP B-NP O
is VBZ B-VP O
intact JJ B-ADJP O
. . O O
Romberg NNP B-NP O
is VBZ B-VP O
negative JJ B-ADJP O
. . O O
Gait NNP B-NP O
and CC I-NP O
station NN I-NP O
are VBP B-VP O
normal JJ B-ADJP O
. . O O
Her PRP$ B-NP O
treponemal JJ I-NP O
test NN I-NP O
for IN B-PP O
syphilis NNS B-NP O
came VBD B-VP O
back RB B-ADJP O
positive JJ I-ADJP O
from IN B-PP O
the DT B-NP O
hospitalization NN I-NP O
in IN B-PP O
July NNP B-NP B-DATE
. . O O
Since IN B-PP O
syphilis NNS B-NP O
, , O O
too RB B-ADVP O
, , O O
could MD B-VP O
cause VB I-VP O
noncaseating JJ B-NP O
granulomas NNS I-NP O
, , O O
and CC O O
she PRP B-NP O
has VBZ B-VP O
clearly RB I-VP O
has VBZ I-VP O
syphilis NNS B-NP O
at IN B-PP O
some DT B-NP O
point NN I-NP O
in IN B-PP O
the DT B-NP O
past NN I-NP O
which WDT B-NP O
was VBD B-VP O
probably RB B-ADVP O
untreated JJ B-ADJP O
, , O O
this DT B-NP O
raises VBZ B-VP O
some DT B-NP O
doubt NN I-NP O
about IN B-PP O
the DT B-NP O
diagnosis NN I-NP O
of IN B-PP O
sarcoidosis NN B-NP O
. . O O
I PRP B-NP O
will MD B-VP O
review VB I-VP O
that DT B-NP O
issue NN I-NP O
with IN B-PP O
you PRP B-NP O
and CC O O
with IN B-PP O
Dr NNP B-NP O
, , O O
Villalpando NNP B-NP B-DOCTOR
. . O O
She PRP B-NP O
had VBD B-VP O
CSF NNP B-NP O
pleocytosis NN I-NP O
in IN B-PP O
July NNP B-NP B-DATE
. . O O
With IN B-PP O
that WDT B-NP O
and CC O O
the DT B-NP O
positive JJ I-NP O
treponemal NN I-NP O
test NN I-NP O
(FTA NN I-NP O
) -RRB- I-NP O
, , O O
she PRP B-NP O
will MD B-VP O
need VB I-VP O
a DT B-NP O
full JJ I-NP O
course NN I-NP O
of IN B-PP O
intravenous JJ B-NP O
penicillin NN I-NP O
for IN B-PP O
presumed VBN B-NP O
neurosyphilis NNS I-NP O
. . O O
I PRP B-NP O
will MD B-VP O
discuss VB I-VP O
arrangements NNS B-NP O
for IN B-PP O
possible JJ B-NP O
outpatient NN I-NP O
management NN I-NP O
of IN B-PP O
hatt NN B-NP O
with IN B-PP O
a DT B-NP O
PICC NNP I-NP O
line NN I-NP O
and CC I-NP O
outpatient NN I-NP O
VNA NN I-NP O
services NNS I-NP O
. . O O
Concerning NN B-VP O
her PRP B-NP O
need NN B-VP O
for IN B-PP O
prednisone NN B-NP O
, , O O
I PRP B-NP O
think VBP B-VP O
that DT B-NP O
will MD B-VP O
depend VB I-VP O
on IN B-PP O
our PRP$ B-NP O
interpretation NN I-NP O
of IN B-PP O
the DT B-NP O
diagnosis NN I-NP O
of IN B-PP O
sarcoidosis NN B-NP O
in IN B-PP O
light NN B-NP O
of IN B-PP O
this DT B-NP O
new JJ I-NP O
diagnosis NN I-NP O
. . O O
If IN B-SBAR O
the DT B-NP O
evidence NN I-NP O
of IN B-PP O
sarcoidosis NN B-NP O
is VBZ B-VP O
not RB O O
strong JJ B-ADJP O
with IN B-PP O
this DT B-NP O
alternative JJ I-NP O
diagnosis NN I-NP O
, , O O
then RB B-ADVP O
we PRP B-NP O
can MD B-VP O
plan VB I-VP O
to TO I-VP O
complete VB I-VP O
the DT B-NP O
course NN I-NP O
of IN B-PP O
penicillin NN B-NP O
and CC I-NP O
taper NN I-NP O
and CC O O
discontinue VB B-VP O
the DT B-NP O
prednisone NN I-NP O
and CC O O
then RB O O
follow VB B-VP O
her PRP$ B-NP O
clinical JJ I-NP O
course NN I-NP O
, , O O
her PRP$ B-NP O
CSF NNP I-NP O
, , O O
and CC O O
her PRP$ B-NP O
syphilis NNS I-NP O
serologies NNS I-NP O
. . O O
Finally RB B-ADVP O
, , O O
from IN B-PP O
the DT B-NP O
MRI NNP I-NP O
of IN B-PP O
7/28 CD B-NP B-DATE
, , O O
shows VBZ B-VP O
a DT B-NP O
couple NN I-NP O
of IN B-PP O
tiny JJ B-NP O
foci NNS I-NP O
of IN B-PP O
restricted JJ B-NP O
diffusion NN I-NP O
in IN B-PP O
the DT B-NP O
left JJ I-NP O
thalamus NN I-NP O
. . O O
These DT O O
are VBP B-VP O
most RBS B-NP O
consistent JJ I-NP O
with IN B-PP O
small JJ B-NP O
vessel NN I-NP O
ischemic JJ I-NP O
strokes NNS I-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
multiple JJ B-NP O
risk NN I-NP O
factors NNS I-NP O
for IN B-PP O
common JJ B-NP O
small JJ I-NP O
vessel NN I-NP O
disease NN I-NP O
and CC I-NP O
stroke NN I-NP O
, , O O
but CC O O
in IN B-PP O
the DT B-NP O
context NN I-NP O
of IN B-PP O
her PRP B-NP O
inflammatory JJ B-NP O
CSF NNP I-NP O
and CC I-NP O
evidence NN I-NP O
of IN B-PP O
prior JJ B-NP O
syphilis NNS I-NP O
, , O O
we PRP B-NP O
must MD B-VP O
also RB I-VP O
consider VB I-VP O
cerebrovascular JJ B-NP O
syphilis NNS I-NP O
as IN B-PP O
the DT B-NP O
likely JJ I-NP O
cause NN I-NP O
of IN B-PP O
this DT B-NP O
. . O O
I PRP B-NP O
would MD B-VP O
recommend VB I-VP O
treatment NN B-NP O
now RB B-ADVP O
with IN B-PP O
a DT B-NP O
14-day JJ I-NP O
course NN I-NP O
of IN B-PP O
high-dose JJ B-NP O
( -LRB- I-NP O
20-24 CD I-NP O
million CD I-NP O
units NNS I-NP O
a DT B-NP O
day NN I-NP O
) -RRB- I-NP O
penicillin NN I-NP O
. . O O
She PRP B-NP O
is VBZ B-VP O
already RB B-ADVP O
on IN B-PP O
prednisone NN B-NP O
which WDT B-NP O
might MD B-VP O
help VB I-VP O
to TO I-VP O
prevent VB I-VP O
any DT B-NP O
possible JJ I-NP O
Jarisch-Herxheimer JJ I-NP O
reaction NN I-NP O
. . O O
I PRP B-NP O
think VBP B-VP O
that IN B-SBAR O
if IN B-SBAR O
she PRP B-NP O
remains VBZ B-VP O
stable JJ B-ADJP O
after IN B-PP O
the DT B-NP O
initiation NN I-NP O
of IN B-PP O
her PRP$ B-NP O
PCN NN I-NP O
therapy NN I-NP O
, , O O
then RB B-ADVP O
we PRP B-NP O
can MD B-VP O
plan VB I-VP O
to TO I-VP O
taper VB I-VP O
and CC O O
then RB O O
discontinue VB B-VP O
the DT B-NP O
prednisone NN I-NP O
, , O O
to TO B-VP O
follow VB I-VP O
her PRP$ B-NP O
clinically RB I-NP O
and CC O O
with IN B-PP O
repeated VBN B-NP O
LP NNP I-NP O
, , O O
and CC O O
determine VB B-VP O
any DT B-NP O
need NN I-NP O
for IN B-PP O
future JJ B-NP O
corticosteroid JJ I-NP O
therapy NN I-NP O
on IN B-PP O
her PRP$ B-NP O
course NN I-NP O
. . O O
Thank VB B-VP O
you PRP B-NP O
for IN B-PP O
this DT B-NP O
consultation NN I-NP O
. . O O
Sincerely RB B-ADVP O
, , O O
Keondre NNP B-NP B-DOCTOR
Viera NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
